Janus kinase inhibitors for the treatment of COVID‐19
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Janus Kinase Inhibitors for the Treatment of COVID‐19." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439404/all/Cladribine_for_people_with_multiple_sclerosis_New. Accessed 20 April 2024.
Janus kinase inhibitors for the treatment of COVID‐19. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439404/all/Cladribine_for_people_with_multiple_sclerosis_New. Accessed April 20, 2024.
Janus kinase inhibitors for the treatment of COVID‐19. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439404/all/Cladribine_for_people_with_multiple_sclerosis_New
Janus Kinase Inhibitors for the Treatment of COVID‐19 [Internet]. In: Cochrane Abstracts. [cited 2024 April 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439404/all/Cladribine_for_people_with_multiple_sclerosis_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Janus kinase inhibitors for the treatment of COVID‐19
ID - 439404
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439404/all/Cladribine_for_people_with_multiple_sclerosis_New
DB - Evidence Central
DP - Unbound Medicine
ER -